HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paclitaxel (taxol) inhibits the arylamine N-acetyltransferase activity and gene expression (mRNA NAT1) and 2-aminofluorene-DNA adduct formation in human bladder carcinoma cells (T24 and TSGH 8301).

Abstract
Acetylator polymorphism in man results from differential expression of human liver N-acetyltransferase. N-Acetyltransferase enzyme activity has been demonstrated to be involved in some types of chemical carcinogenesis. Paclitaxel (taxol) had been shown to affect N-acetyltransferase activity of human lung cancer cells. In this study, paclitaxel was chosen to investigate the effects of arylamine N-acetyltransferase activity (N-acetylation of substrate), gene expression and 2-aminofluorene-DNA adduct formation in human bladder carcinoma cell lines (T24 and TSGH 8301). The N-acetyltransferase activity (N-acetylation of substrates) was determined by high performance liquid chromatography assaying for the amounts of acetylated 2-aminofluorene and p-aminobenzoic acid and nonacetylated 2-aminofluorene and p-aminobenzoic acid. Intact human bladder carcinoma T24 and TSGH 8301 cells were used for examining N-acetyltransferase activity, gene expression and 2-aminofluorene-DNA adduct formation. The results demonstrated that the N-acetyltransferase activity, gene expression (NAT1 mRNA) and 2-aminofluorene-DNA adduct formation in intact human bladder carcinoma cells were inhibited and decreased by paclitaxel in a dose-dependent manner. The effects of paclitaxel on the apparent values of Km and Vmax of N-acetyltransferase enzyme from intact human bladder carcinoma cells were also determined in these cell lines. A marked influence of paclitaxel was observed on the decreasing apparent values of Km and Vmax from intact human bladder carcinoma cells (T24 and TSGH 8301). Thus, paclitaxel is an uncompetitive inhibitor to the NAT enzyme.
AuthorsChing-Chiang Yang, Guang-Wei Chen, Hsueh-Fu Lu, Der-Yuan Wang, Yi-Shuan Chen, Jing-Gung Chung
JournalPharmacology & toxicology (Pharmacol Toxicol) Vol. 92 Issue 6 Pg. 287-94 (Jun 2003) ISSN: 0901-9928 [Print] Denmark
PMID12787261 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-aminofluorene-DNA complex
  • Antineoplastic Agents
  • DNA Adducts
  • Fluorenes
  • Isoenzymes
  • RNA, Messenger
  • Acetyltransferases
  • Arylamine N-Acetyltransferase
  • N-acetyltransferase 1
  • Paclitaxel
  • 4-Aminobenzoic Acid
Topics
  • 4-Aminobenzoic Acid (metabolism)
  • Acetylation
  • Acetyltransferases (antagonists & inhibitors, genetics)
  • Antineoplastic Agents (pharmacology)
  • Arylamine N-Acetyltransferase
  • Chromatography, High Pressure Liquid
  • DNA Adducts (antagonists & inhibitors, biosynthesis, genetics)
  • Dose-Response Relationship, Drug
  • Female
  • Fluorenes (antagonists & inhibitors)
  • Humans
  • In Vitro Techniques
  • Isoenzymes
  • Male
  • Paclitaxel (pharmacology)
  • RNA, Messenger (antagonists & inhibitors, biosynthesis)
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: